Table 3 Incidence of most frequent adverse events.
Adverse event | Number of patients (%) |
|---|---|
Musculoskeletal and connective tissue disorders | 53 (38.1) |
Asthenia | 48 (34.5) |
Injection site reactions | 30 (21.6) |
Nausea | 18 (12.9) |
Decreased appetite | 18 (12.9) |
Diarrhea | 15 (10.8) |
Headache | 13 (9.4) |
Dyspnea | 13 (9.4) |
Peripheral neuropathy | 11 (7.9) |
Palmar-plantar erythrodysesthesia syndrome | 11 (7.9) |
Vomiting | 10 (7.2) |
Abdominal pain—upper | 8 (5.8) |
Neutropenia | 7 (5.0) |
Constipation | 7 (5.0) |
Rash | 7 (5.0) |
Hot flush | 7 (5.0) |
